Healthtech Fundraising: Active VCs, FDA & Reimbursement
How to raise venture capital for a healthtech, digital health, medtech, or diagnostics startup in 2026.
How to Raise Venture Capital for a Healthtech or Digital Health Startup
Healthtech spans digital health, medtech, diagnostics, care delivery, and health infrastructure — attracting $25B+ of venture capital in 2025. The category has its own investor community, its own regulatory pathways (FDA 510(k), De Novo, PMA, CE Mark), and its own revenue models (CPT codes, DRG bundles, VBC contracts).
Why healthtech is a distinct fundraising category
Healthtech companies must navigate FDA/CE regulatory approval, HIPAA/GDPR compliance, payer contracting, provider adoption cycles, and CMS reimbursement pathways. Timelines and diligence norms differ materially from generalist SaaS or consumer categories.
The most active healthtech VCs
Digital health leaders: General Catalyst, a16z Bio + Health, Oak HC/FT, 7wireVentures, Define Ventures, Flare Capital, LRVHealth, Optum Ventures, Providence Ventures, .406 Ventures, F-Prime Capital, Venrock, Bessemer Healthcare, and Rock Health Capital.
Medtech and diagnostics: Deerfield, RA Capital, Cormorant, ARCH, Section 32, Norwest Venture Partners, US Venture Partners, and Longitude Capital.
European specialists: MTIP, Nina Capital, Heal Capital, Karma Ventures Health, Sofinnova Digital Health, Cathay Health, and LSP Health Economics Fund.
FDA and CE regulatory pathways
510(k) clearance (substantially equivalent to predicate), De Novo (novel low-to-moderate risk), and PMA (high-risk Class III). SaMD (Software as a Medical Device) and AI/ML-enabled device pathways evolving under FDA Pre-Cert and 2024 AI/ML guidance. CE Mark under EU MDR/IVDR is a longer, more evidence-heavy pathway than pre-Brexit.
Reimbursement and payer contracting
CPT Category I codes (established), Category III (emerging), HCPCS Level II, DRG bundles, and CMS RPM/RTM/PIN/CCM codes for digital health. Value-based care contracts with health systems and payers (per-member-per-month capitation, shared savings) are increasingly the primary revenue path for digital health.
Common mistakes when raising for healthtech
Underestimating FDA/CE timelines and cost. Weak reimbursement strategy (no CPT/HCPCS pathway modeled). Building without payer or provider LOIs. HIPAA/GDPR compliance gaps at Series A diligence.
Frequently asked questions
Which are the most active healthtech VCs in 2026?
General Catalyst, a16z Bio+Health, Oak HC/FT, 7wireVentures, Define Ventures, Flare Capital, LRVHealth, Optum Ventures, Providence Ventures, .406, F-Prime, Venrock, and Bessemer Healthcare are the most consistent leads.
How long does FDA 510(k) clearance take?
3–9 months typical for a well-prepared submission with clear predicate. De Novo and PMA are materially longer (12–36 months) and more expensive.
What reimbursement pathways matter?
CPT Category I and III codes, HCPCS Level II, DRG bundles, and CMS RPM/RTM/PIN/CCM codes for digital health. Value-based care contracts with payers and health systems are increasingly primary.
Do I need HIPAA compliance at seed?
Yes if handling PHI. BAA templates, encryption, access controls, and audit logging are table stakes. SOC 2 Type II is expected by Series A.
How is medtech different from digital health?
Medtech (physical devices/diagnostics) has higher capex, longer regulatory timelines, and clinical trial requirements. Digital health is faster to market but harder to defend reimbursement.
